Table 5.
Laboratory features of the SARS-CoV-2-positive patients of the Infective Disease Unit.
| Biochemical Data | SARS-CoV-2-Positive Cases (n = 444) | |
|---|---|---|
| Reference Values | (Mean Values ± SE) | |
| Hematocrit | 38–54 | 38.05 ± 0.8 |
| Hemoglobin (g/L) | 12.5–18 | 12.78 ± 1.2 |
| Erythrocyte (×1012/L) | 4–5,700,000 | 4.39 ± 0.27 |
| Platelets (×109/L) | 150–450 | 226.61 ± 21.1 |
| Leucocytes (×109/L) | 4–100,000 | 6.89 ± 2.5 |
| Lymphocytes (%) | 12–50.0 | 17.59 ± 4.67 |
| Basophils (%) | 0–2 | 0.3 ± 0.15 |
| Neutrophils (%) | 37–75 | 75.85 ± 3.6 |
| Eosinophils (%) | 0–7 | 0.62 ± 0.16 |
| Monocytes (%) | 3–12.0 | 6.67 ± 0.78 |
| Azotemia (mg/dL) | 15–50 | 51.2 ± 34.7 |
| HDL-CHOL (mg/dL) | 45–65 | 29.59 ± 5.32 |
| CHOL (mg/dL) | 160–220 | 147.89 ± 17.4 |
| APTT—Seconds | 20–40 | 30.77 ± 5.28 |
| ATIII—Antitrombin (%) | 75–129 | 119.78 ± 20.85 |
| Fibrinogen (mg/dL) | 200–400 | 568.8 ± 105.29 |
| Gamma GT | 8–61.0 | 47.89 ± 18.61 |
| GOT/AST (U/L) | 0–45.0 | 41.44 ± 9.78 |
| GPT/ALT (U/L) | 0–50.0 | 31.82 ± 22.12 |
| LDH (IU/L) | 122–222 | 316.3 ± 75.47 |
| MCH (FL) | 78–98 | 29.1 ± 1.03 |
| MCHC (g/dL) | 30–36 | 33.45 ± 0.87 |
| MCV | 80–96.0 | 85.9 ± 3.81 |
| CRP (mg/L) | 5–6.0; 500–1.000 # | 89.74 ± 29.79 |
| PT (%) | 80–120 | 82.71 ± 12.36 |
| TG (mg/dL) | 50–155 | 119.21 ± 23.45 |
Abbreviations: LT—alanine aminotransferase; AST—aspartate aminotransferase; APTT—Activated Partial Thromboplastin Time; Gamma GT—gamma glutamyl transferase; MCH—mean cell hemoglobin; MCHC—mean corpuscular hemoglobin concentration; MCV—mean cell volume; TP—total protein; TG—triglyceride; CHOL—cholesterol; HDL-C—high-density-lipoprotein cholesterol; LDH—lactic dehydrogenase; CRP—C reactive protein. # Inflammation range. Bold p < 0.05